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Objectives: Globally, the number of people with dementia who have palliative care
needs will increase fourfold over the next 40 years. The Empowering Better End-of-
Life Dementia Care (EMBED-Care) Programme aims to deliver a step change in care
through a large sequential study, spanning multiple work streams.
Methods: We will use mixed methods across settings where people with dementia live
and die: their own homes, care homes, and hospitals. Beginning with policy syntheses
and reviews of interventions, we will develop a conceptual framework and underpinning
theory of change. We will use linked data sets to explore current service use, care transi-
tions, and inequalities and predict future need for end-of-life dementia care. Longitudinal
cohort studies of people with dementia (including young onset and prion dementias) and
their carers will describe care transitions, quality of life, symptoms, formal and informal
care provision, and costs. Data will be synthesised, underpinned by the Knowledge-to-
Action Implementation Framework, to design a novel complex intervention to support
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assessment, decision making, and communication between patients, carers, and inter-
professional teams. This will be feasibility and pilot tested in UK settings. Patient and
public involvement and engagement, innovative work with artists, policymakers, and
third sector organisations are embedded to drive impact. We will build research capacity
and develop an international network for excellence in dementia palliative care.
Conclusions: EMBED-Care will help us understand current and future need, develop
novel cost-effective care innovations, build research capacity, and promote interna-
tional collaborations in research and practice to ensure people live and die well with
dementia.
K E YWORD S
dementia, end-of-life care, family caregivers, health economics, health services research,
implementation science, palliative care, policy, quality of life, symptom assessment
1 | INTRODUCTION
1.1 | Dying with dementia
One-third of people aged over 65 will die with dementia,1 the com-
monest cause of death in the United Kingdom. By 2040, it is esti-
mated that 220 000 people will die each year with dementia in
England and Wales, and many will have palliative care needs.2
Although people may die in the early or moderate stages from dis-
eases other than dementia, about one-third of people with dementia
live until advanced stages.3 Globally, the number of people dying with
dementia who experience serious health-related suffering will
increase fourfold over the next 40 years.4 Most live and die with
dementia and other conditions that are becoming increasingly com-
mon with advancing age (eg, diabetes and heart disease).
As dementia and multi-morbidities progress, symptoms such as
pain and breathlessness3,5 are common and cause significant distress
for the person and their carers.6 People with dementia and their
families may struggle to express their needs and concerns, leaving
problems under detected and undertreated over the last months and
years of life. Death can be unpredictable, and uncertainty is
inherent,7 with inequity of access to palliative care.5 A shift is
required, from delivering care based on an often unreliable prognosis
to care that is responsive and based on need, whatever the stage of
dementia.
1.2 | The role of palliative care for people with
dementia
Dementia is the most feared disease for people aged over 60 years,8
but there is less awareness of dementia as a life limiting illness where
a “good death” is possible. The concept that a person can “live well”
with dementia is promoted widely and is beginning to gain widespread
understanding by the public. That people can “die well” with dementia
is less accepted.
Most people with dementia die in care homes (58%).9 England
has one of the highest rates of hospital death in dementia (40%),10
and few people die at home.11,12 Avoiding care transitions is an
important goal, but policy has focussed mainly on promoting death in
usual place of residence rather than on quality of dying.12 Carers and
people with dementia report comfort and quality of life (QoL) should
be the main goals of care.13 Recent NICE Dementia Guidance states
people with dementia should receive flexible, needs-based palliative
care that takes into account the unpredictable progression.14
Palliative care is patient-centred care in advanced disease (see
Box 1).15 The cornerstone is a focus on detailed detection and assess-
ment of physical, psychosocial, and spiritual needs, with regular review
and careful management. This needs-based approach allows the person,
their carers, and staff to focus on living well, maximising comfort, QoL,
and managing uncertainty. Palliative care models for other life-limiting
conditions reduce symptom burden and are cost effective.16 A palliative
care approach for people with dementia is recommended17 but not
Key Points
• Dementia palliative care is an under developed
priority area.
• We lack cost-effective interventions to empower people
with dementia, carers and staff, to identify and meet
physical, psychosocial and spiritual needs, across care set-
tings and transitions.
• We will undertake policy and literature reviews, large
data and cohort studies, knowledge synthesis, develop
and evaluate interventions, underpinned by a new con-
ceptual framework for dementia palliative care.
• Research is guided by patient and public involvement,
innovative work with artists, policymakers and third sec-
tor organisations amend accordingly.
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widely used in practice. Most care for people with dementia is delivered
via “generalist” staff who frequently deal with palliative care in their role
(ie, general practitioner [GP], community and mental health nurses, and
ambulance and care home staff) without specialist training or support. A
palliative care approach is often started in a crisis or when dying is immi-
nent5 but should be integrated earlier into routine practice by generalist
staff and be “everybody's business.”18
Significant deficits in knowledge and service provision remain;
palliative care is a neglected area of dementia research.19 Prior studies
have focussed on the advanced stages of dementia in care home resi-
dents.3,5,13 There are no UK studies of palliative care need in those
with early-stage or moderate dementia who may be dying from other
life limiting diseases or co-morbidities, which have different profiles of
symptoms and carer experiences, compared with those dying from
advanced dementia, or in people with young onset and rapidly pro-
gressive dementias (an archetype of which is prion disease). The latter
conditions pose special challenges, with rapid deterioration, a lack of
time to prepare for death and are highly distressing for carers who
may also be managing employment and younger families. Services are
patchy, inequitable, and not always age appropriate.20,21
Given the increasing numbers of people who will die with demen-
tia, the distress this can cause carers, the pressures on staff to manage
dying in the context of an unpredictable trajectory and funding pres-
sures on the health system, we need to develop new knowledge and
innovative cost-effective care. New interventions will need to
empower people with dementia of all ages, carers, and staff, to iden-
tify and act upon changing physical, psychosocial, and spiritual needs,
addressing unmet needs across care settings and facilitating the trans-
fer of information across transitions.
The Empowering Better End-of-Life Dementia Care (EMBED-Care)
Programme aims to generate new knowledge to promote these neces-
sary sustained improvements in care. EMBED-Care began in January
2019 and runs until December 2023. It is funded by the UK Economic
and Social Research Council (ESRC) and the National Institute for Health
Research (NIHR) under their dementia research initiative 2018.
1.3 | Previous work informing EMBED-Care
In previous studies, we found high levels of persistent pain and dis-
tressing symptoms in care home residents with severe dementia5 and
increasing distress in carers.6,22 Our routine data analyses show place
of death is moving from hospital to the community10 but increasing
numbers of people with dementia attend emergency departments in
the last year of life.23 We have developed decision aids, using a co-
design approach, based on heuristics24,25 (rules of thumb) to manage
difficult decisions towards the end of life.25 We developed, validated,
and refined the Palliative Care Outcome Scale (POS, http://pos-pal.
org/), a tool to improve comprehensive assessment, identification of
unmet needs, screening, communication, care, and outcomes in life-
limiting disease in routine care.26 Systematic reviews27 and empirical,
quantitative, and qualitative work28,29 have informed development of
the Integrated-POS for Dementia (IPOS-Dem).30,31 This multifaceted
tool takes a person-centred approach,27 which asks about the per-
son's most important concerns, and then assesses symptoms and
unmet needs, enabling carers and nonclinical staff to identify needs
and plan and improve care.31 Using realist methods, we developed an
understanding of integration,32 facilitators and barriers to good
dementia palliative care,33 and guidance for evaluation of regional
health care strategies and policies.34 The EMBED-Care Programme
will add to our existing knowledge and build on this work, developing
a complex intervention based on our research to identify unmet needs
using IPOS-Dem and providing practitioners with resources to inform
clinical decision making, communication, and management of these
needs (ie, heuristics or clinical “rules of thumb”).
2 | AIMS AND OBJECTIVES
Our overall aim is to promote a “step change” in care for people with
dementia and their carers to enable delivery of timely person-centred
care, to identify unmet needs and improve outcomes, including com-
fort and QoL, towards end of life. Each of six-interdependent work
streams (WSs) will deliver new knowledge and sequentially build a
complex intervention to improve palliative dementia care. Our objec-
tives are to:
1. Synthesise health and social care policy, guidance, and evidence
for the effectiveness of interventions to improve QoL, to under-
stand context, inequalities, workforce, and levers for change. We
will use this data to develop our programme theory to underpin
our research (WS 1);
BOX 1 Definitions of palliative and end of life care
Palliative care is the active, total care of the patient whose
disease is not responsive to curative treatment. Control of
pain, of other symptoms, and of social, psychological, and
spiritual problems is paramount. Palliative care is interdisci-
plinary in its approach and encompasses the patient, the
family, and the community in its scope. In a sense, palliative
care is to offer the most basic concept of care—that of pro-
viding for the needs of the patient wherever he or she is
cared for, either at home or in the hospital. Palliative care
affirms life and regards dying as a normal process; it neither
hastens nor postpones death. It sets out to preserve the
best possible quality of life until death.
End-of-life care may be used synonymously with pallia-
tive care or hospice care, with end of life understood as an
extended period of 1 to 2 years during which the patient/
family and health professionals become aware of the life-
limiting nature of their illness. End-of-life care may also be
understood more specifically as comprehensive care for
dying patients in the last few hours or days of life.52
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2. Develop new knowledge on current service use, care transitions,
and inequalities in care using linked datasets (WS 2).
3. Describe unmet needs, comfort, care transitions, QoL, formal and
informal care, and societal costs in longitudinal cohort studies (WS 3);
4. Synthesise evidence and knowledge generated from WSs 1 to
3, to provide a foundation and inform recommendations and com-
ponents for our new intervention (WS 4);
5. Design the novel EMBED-Care intervention package (WS 5);
6. Test in community settings the feasibility and acceptability of the
EMBED-Care intervention, and pilot methods for a full cluster
randomised controlled trial (RCT) (WS 6);
7. Create a network for excellence in dementia palliative care (NEDPC)
with UK and international partners, to leverage a sustained step
change in care. We will involve people affected by dementia, carers,
staff, researchers, third sector, and policymakers to stimulate a public
discourse on dying with dementia and provide a platform for work-
force development, research, education, implementation, policy, and
public engagement.
3 | METHODS
We first describe the key perspectives and theoretical models that
underpin the programme followed by aspects of the work that run
through the programme, including patient and public involvement and
engagement activities. We then give an overview of the individual
WSs and how these will work together to build knowledge and
develop interventions to improve care. The overall structure of the
programme is illustrated in Figure 1.
3.1 | Conceptual framework and implementation
A conceptual framework of integrated palliative dementia care will
underpin the programme. A theory of change (ToC) model35 will be
used to understand how the EMBED-Care intervention can facili-
tate integrated palliative dementia care using a theory-driven
approach. This will describe organisational context, the challenges
facing integrated palliative dementia care, implementation require-
ments, and linkages between processes and intended outcomes.
The framework will provide theoretical cohesion, inform the
choice of research methods, for example the selection of tools and
outcomes, and be refined across the programme as we build
knowledge.
Implementation is considered from the beginning of the pro-
gramme. The Knowledge-to-Action (KTA) Implementation Frame-
work36 is designed to guide the translation of research evidence into
practice and informs all WSs. This iterative model includes all pro-
cesses for intervention development from initial research to imple-
mentation. It ensures user perspectives and contextual understanding
are included from the earliest stage. It comprises a central core of
knowledge creation: knowledge inquiry (WSs 1-3), synthesis (WS 4),
and products (WSs 5 and 6), surrounded by an action cycle where we
will, in feasibility and pilot trials, consider adaptations required to local
context, tailor and implement the intervention, and evaluate processes
and outcomes.
3.2 | Involvement of people with dementia and
their carers
Our programme is built on research priorities identified by people
affected by dementia, the Alzheimer's Society and James Lind Alli-
ance.37 Active and collaborative involvement is integrated throughout.
Experts by experience, one of whom is a co-applicant, helped write
the proposal. We held a workshop funded by the NIHR Research
Design Service “Enabling Involvement Fund,” which led to changes
including developing thinking around comfort as a key outcome and
widening to include QoL, endorsing the use of the term “carer” for
family and friend carers and strengthening our social media strategy.
F IGURE 1 Overview of the EMBED-
Care Programme. EMBED-Care,
Empowering Better End-of-Life Dementia
Care; WS, work stream
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Our study reference panel will comprise eight experts by experi-
ence: carers and people with dementia, including young onset and
prion diseases. It will meet every 4 to 6 months with programme and
WS leads and their teams to inform important aspects of the work.
The panel will contribute to study materials such as information
sheets to improve accessibility, develop qualitative topic guides, and
support data analysis. They will inform broader public and policy
engagement, for example, designing of our YouGov social attitudes
survey and contributing personal narratives. We will work with people
living with dementia holding four workshops across the United King-
dom with the Dementia Engagement and Empowerment Project
(DEEP) at key stages of the programme.
3.3 | Engagement
We will deliver a novel programme of public and policy engagement
targeting different sections of society to maximise knowledge exchange.
We will work with Science Gallery London (https://london.sciencegallery.
com/engage), a space hosting participatory exhibitions, linking art, science
and health, the university, and the local community, particularly young
people. Our objective is to start conversations among groups who may
not have been previously engaged with this issue but are likely to experi-
ence dementia in the future as relatives or carers. Key beneficiaries are
people with dementia and their families and friends, with whom we hope
to build awareness and understanding; service commissioners, voluntary
sector organisations, and policymakers who we need to equip with infor-
mation to drive change; and health and social care practitioners to ensure
the intervention is embedded in day-to-day practice.
Our impact plan is based around three phases.
1. Early programme: a co-creation model to shape our research and
engagement strategy. Activities include a co-creation workshop
with young people, which will inform an art installation by commis-
sioned artists from the Science Gallery London network. We will
hold public workshops to identify questions for a nationally repre-
sentative YouGov survey to understand knowledge, attitudes, pri-
orities, and concerns around dying with dementia. A policy lab,
which is an interactive event bringing together researchers and
policymakers using co-design techniques, will define the informa-
tion policymakers require and how we can best work with them.
2. Mid programme: a collaborative model to promote discussion of
emerging research findings through public workshops, social
media, and policy labs. We will work with Hospice UK to produce
educational materials from emerging findings, disseminated
directly via project Extension for Community Healthcare Out-
comes (ECHO) super hub, a knowledge-sharing network of gener-
alists and specialists (ie, care homes, acute and community health
trusts, and social care) who form communities of practice with
trained facilitators for learning via videoconferencing and virtual
meetings.
3. Late programme: a dissemination model to share research findings
and refine messages. This includes the production of shareable
digital content, high-profile public debates, knowledge exchange
events with commissioners and policymakers, and parliamentary
engagement.
Monitoring and evaluation of impact will be led by a specialist
evaluation consultant from SGL's network. Working with the research
team, they will employ mixed methods, pre- and post-participation
questionnaires deployed at each activity, semi-structured interviews,
and focus groups.
The Network for Excellence in Palliative Dementia Care will bring
together the third sector, academics, policymakers, advisors, and
international partner organisations from across the specialities of
dementia and palliative care, including the Worldwide Hospice Pallia-
tive Care Alliance, Marie Curie, Hospice UK, Dementia UK,
Alzheimer's Society, CJD Support Network, and YoungDementia
UK. The NEPDC facilitates input from this broad range of stake-
holders into design and delivery of this and future research and sup-
ports dissemination and implementation of research outputs. The
Network for Excellence in Palliative Dementia Care will be facilitated
through our website, regular newsletters, and knowledge exchange
events and will facilitate dissemination of our findings and learning to
stakeholders including people with dementia, carers, and staff.
3.4 | Capacity building
We have included four PhD studentships, linked to local ESRC gradu-
ate schools, in the programme to build capacity at doctoral level:
(a) understanding care transitions in the last years of life for people
with dementia (linked to WS 2), (b) identifying palliative care need in
young onset dementia (linked to WS 3), (c) appraising implementation
and sustainment of innovations in care homes to manage palliative
care needs for people (linked to WSs 4-6); and (d) empowering infor-
mal carers of people with dementia living at home: development and
use of decision support tools (linked to WSs 4-6). Mid-career
researchers will develop skills by leading WS and broadening their
networks, supported and mentored by senior academics. They will
have dedicated time to attend management training and undertake
placements in policy units and with partner charities. Additional sup-
port for PhD students and mid-career researchers is provided by the
INTERDEM academy (http://interdem.org/?page_id=4636). This will
deliver a cohort of young researchers with specialism in palliative
dementia care, linked to international networks through INTERDEM
skilled in delivering impactful research and its subsequent
implementation.
3.5 | Research methods
Methods will change and develop during the programme as knowl-
edge is built at each stage. Below, we give an overview of each WS
and how they will work together. Indicative details of methods,
populations, and deliverables for each WS are given in Table 1.
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TABLE 1 Overview of work streams and methods
Main Objective Main Methods Data Sources/Participants Key Deliverables
Work
stream 1
Synthesise health and social
care policy and guidance to
understand context,
inequalities, workforce, and
levers for change.
Informed by KTA framework
and theory of change (ToC)
specific to complex
interventions, we will map
intervention causal pathways
to achieve change and
impact.
1. Overview of systematic
reviews on service delivery
models in palliative care and
dementia.
2. Policy review of UK and
international health and
social care: qualitative
documentary analysis and
summative content analysis.
1. Relevant reviews, combined
MeSH and text terms,
search from 2000 to end
date in databases for social
care (IBSS, Social Policy, and
Practice), health (MEDLINE,
EMBASE, and CINAHL), and
systematic reviews
(Cochrane, DoPHER,
and DARE).
2. Review of UK and
international policy and
strategies with widened
focus to dementia and
palliative care.
3. Focus groups of health and
social care practitioners,
policymakers. and carers
will review findings to
ensure knowledge
generated is relevant and
useful.
1. Conceptual framework of
integrated palliative
dementia care;
2. Practical model of
integrated palliative
dementia care across
services; and
3. Description of key
intervention components,
implementation, workforce
needs, sustainability and
scalability, and context to
inform policy briefings and
support intervention
uptake.
Work
stream 2
Develop new knowledge on
current service use, care
transitions, and inequalities
in care using linked data sets.
Retrospective observational
study: to describe patterns of
health service use (including
NHS costs). Statistical
modelling to understand
inequalities and co-morbidity
and predict trends and future
projections of health service
use.
South London and Maudsley
National Health Service
(NHS) Foundation Trust
Biomedical Research Centre
(SLaM BRC) Case Register
and Clinical Record
Interactive Search (CRIS).
Population with clinical
diagnosis of dementia (ICD-
10) and open-text data
search.
4. Data on service use,
inequalities, and transition
of people who died with
dementia, and how they
transition through the
health care system to
inform programme theory
and subsequent works
streams.
5. Methodological innovation,
for example, linking
community palliative care
records to other large
data sets.
Work
stream 3
Describe unmet needs comfort,
care transitions, QoL, formal
and informal care, and
societal costs
Longitudinal cohort: people
with dementia and their
carers. Measures informed
by WSs 1 and 2 and PPI
panel to include
demographics, frailty, co-
morbidity, and unmet needs
(IPOS-Dem) at baseline and
3-monthly for 9 months.
Qualitative study: explore care
transitions, empowerment in
managing care, using
individual interviews with
carers at baseline, 3 months
and 6 months. We will use
thematic analysis,
triangulated with our
quantitative data.
Longitudinal cohort:
294 people living at home or
in care homes, rural, city/
suburban areas. Inclusion
criteria guided by WS
2. Recruited via networks, ie,
NIHR Enabling Research in
Care Homes, NIHR Join
Dementia Research, and
NHS trusts. Embedded
studies of people with prion
dementias from National
Prion Clinic UCLH and MRC
Prion Unit and young-onset
dementia (National Hospital
for Neurology and
Neurosurgery Queen
Square).
Qualitative study: 25 dyads
(10 young onset) comprising
person with dementia and
carer. Separate interview
with main practitioner
6. New knowledge on unmet
palliative care needs and
their impact defines main
topics for decision support
tools developed in WSs
4 and 5.
7. Case studies for detailed
understanding of how
“good” care works will
inform WS 4
8. New knowledge on service
use, inequalities, and
transitions through the
system will refine
conceptual framework and
inform policy.
9. New data on young onset/
prion dementias for future
research, intervention
studies, and policy.
10. Data on cohort
characteristics and need
inform participant
(Continues)
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TABLE 1 (Continued)
Main Objective Main Methods Data Sources/Participants Key Deliverables
providing care. Maximum
variation sampling to
understand “standard” and
“good” care.
selection criteria for trials
in WS 6.
Work
stream 4
Synthesise evidence and
knowledge from WSs 1 to
3, to provide a foundation
and inform
recommendations and
components for our new
intervention.
Data synthesis using a matrix
approach that draws on
framework analysis and
systematically evaluates
evidence for strategies to
address unmet needs.
Focus groups will appraise the
matrix to help understand
and organise the data and
introduce conflicting
evidence and ideas that
provide a rich “real world”
discussion.
WS 1 policy reviews, WS
2 linked data sets analysis,
and WS 3 cohort studies
Focus groups: (7-10
participants per group) for
different target populations;
people with dementia via
DEEP workshop 4, carers,
and a wide range of health
and social care practitioners.
11. Comprehensive synthesis
matrix of best available
evidence (WSs 1-3) for
meeting unmet palliative
care needs, reviewed by
key stakeholders for
applicability across care
contexts, to provide the
evidence base and
recommendations for WS
5 co-design.
12. Qualitative data on
stakeholder development
of key intervention
components.
Work
stream 5
Design the novel EMBED-Care
intervention package
Co-design groups. Three groups, up to
10 participants:
(a) Practitioners from across
settings and disciplines;
(b) current and former carers,
including those caring for
people with young onset and
prion dementias; (c) people
with mild dementia,
purposively recruited to
maximise sample diversity,
via sources described in WS
3.
13. Co-designed, user-tested
EMBED-Care intervention
for WS 6, including
implementation strategy
and processes for care
homes and community
settings and training
package
14. Methodological
development in co-design
of complex palliative
dementia care intervention
Work
stream 6
Test in community settings the
feasibility and acceptability
of the EMBED-Care
intervention. Pilot methods
for a full cluster randomised
controlled trial
Mixed-methods feasibility
study and pilot cluster-
randomised controlled trial
Feasibility study data analysis:
completeness of outcome
data, including completion of
the IPOS-Dem and
frequency of use. Directed
content analysis is used for
qualitative data, underpinned
by our theoretical model.
Pilot data analysis: levels of
missing data will be assessed
and evaluated. Recruitment
and attrition rates will be
estimated using proportions
with associated 95% CI. We
will estimate the difference
(and CI) in our main clinical
outcomes between trial
arms, using appropriate
regression models adjusted
for baseline values. This will
inform sample size
calculations for a full
cluster RCT.
Feasibility study: four clusters
(two care homes, two
communities of practice
(CoP-multidisciplinary teams
providing care to people with
complex care needs at home
or in care homes), chosen to
demonstrate feasibility of
intervention delivery in both
settings. We aim to recruit
40 participants, with a
minimum of 8-10 per cluster.
Pilot study: 10 settings (six care
homes, four CoP)
randomised by trial
statistician to five
interventions and five
controls. Numbers chosen
pragmatically to be sufficient
to pilot recruitment,
acceptance of randomisation
and attrition. We aim to
recruit 100 participants,
minimum of eight per cluster.
15. Feasibility and pilot-tested
intervention
16. Methods (including health
economics) and sample
size to inform full cluster
RCT (if warranted)
17. Detailed understanding of
implementation and
context requirements for
EMBED-Care intervention
(Continues)
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3.5.1 | WS 1: Developing a conceptual framework
of integrated palliative dementia care
The underpinning conceptual framework will be refined as we build
knowledge through the programme. Our aim is to define a practical
service delivery model of integrated palliative dementia care for peo-
ple with dementia and their carers to increase comfort and QoL across
health and social care services. To do this, we need to understand
what the key components of this should be and consider sustainabil-
ity, costs, and workforce implications.
We will complete two reviews: (a) an overview of systematic
reviews on service delivery models in palliative and dementia care to
conceptualise palliative dementia care and inform our initial ToC and
(b) a review of health and social care policy using qualitative docu-
mentary analysis to understand: national and international context,
integration of palliative and dementia care, inequalities, workforce
needs, and policy levers for change.34,38 Focus groups involving health
and social care practitioners, policymakers, and carers and a DEEP
workshop with people with dementia will review the findings to
ensure that the knowledge generated is relevant and useful.35,36
3.5.2 | WS 2: New knowledge on service use,
inequalities, and future population need
Our aim is to study health service use and transitions between care
settings among people with dementia as they near the end of life
using large linked health care data sets from mental health and general
hospital trusts. This will be a retrospective observational study
centred on the South London and Maudsley National Health Service
(NHS) Foundation Trust Biomedical Research Centre (SLaM BRC)
Case Register and its Clinical Record Interactive Search (CRIS). SLaM
provides mental health and dementia services to over 1.2 million resi-
dents in four south London boroughs (Croydon, Lambeth, Lewisham,
and Southwark). The register is a research repository of anonymised,
structured, and open-text data from electronic records within SLaM
(over 400 000 patients), enriched with a range of external data link-
ages and natural language-processing algorithms to extract structured
data from free text.39 CRIS has been previously used to investigate
end-of-life issues in dementia,23 and this WS builds on WS 1 reviews
and will inform the case for new models of dementia palliative care.
We will specifically investigate key factors, including inequalities and
multi-morbidity, associated with health service use in the last 2 years
of life for people with a previous diagnosis of dementia of any severity
and use this information to project future need. Analysis will be
informed by our prior work and the programme conceptual frame-
work. We will hold a second DEEP workshop to consider the implica-
tions of findings for people with dementia.
3.5.3 | WS 3: Cohort studies on unmet palliative
care needs
The aim of this WS is to understand unmet palliative care needs in
people at all stages of dementia, including those in the early and mod-
erate stages who may be dying from other illnesses. We will include
sub-cohorts with young onset and rapidly progressive (prion) demen-
tias. This will be a prospective longitudinal mixed method cohort study
involving people with dementia (all subtypes) over 9 months. Inclusion
criteria will be informed by WS 2 and our prior studies. Study measures
will be informed by WSs 1 and 2 and our patient and public involve-
ment (PPI) Study Reference Panel. We will define unmet needs using
tools such as IPOS-Dem.30 Outcomes will include validated scales for
comfort and symptom management and care transitions. We will
TABLE 1 (Continued)
Main Objective Main Methods Data Sources/Participants Key Deliverables
Study flow reported per
CONSORT for randomised
feasibility and pilot studies.
Economic evaluation: health
and social services
perspective, describing costs
of delivering the intervention
including support,
equipment, supervision and
monitoring, staff recruitment,
training and project
management. Resource
utilisation will be multiplied
by unit costs to estimate
individual patient costs at
baseline and over 6 months.
Abbreviations: DEEP, Dementia Engagement and Empowerment Project; EMBED-Dem, Empowering Better End-of-Life Dementia Care; IPOS-Dem,
Integrated Palliative Care Outcome Scale for Dementia; KTA, Knowledge to Action; NIHR, National Institute for Health Research; PPI, patient and public
involvement; QoL, quality of life; RCT, randomised controlled trial; WS, work steam.
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measure carer unmet needs and outcomes such as anxiety, depression,
and anticipatory grief, to explore how these are associated with unmet
palliative care need. If participants die, we will interview carers post-
bereavement to understand final care transitions and care quality.
Health economics
Our aims in the economic evaluation are to assess participants' QoL and
estimate costs of care from health and social care (NHS) cost perspectives.
This will include social services and community support, day care services,
outreach, symptom control, and respite services. Unit costs will be
obtained from Personal Social Services Research Unit and National End of
Life Care Intelligence Network.
Unpaid carers often provide essential support and care to patients
with dementia. Their contribution to care needs to be recognised and
valued. A failure to do so risks undervaluing the total cost of care.
Thus, in addition to health and social care costs, our analysis will take
into account the contribution of unpaid carers as if they were paid at
the same rate as a paid carer. Total cost estimates will also be
expressed as increments per 1 point change in our primary outcome,
IPOS-Dem. Quality-adjusted life years (QALYs) will be calculated
using the EQ-5D-5L values from each follow-up point from baseline
to 9 months. In the population nearing the end of life, it is unclear
how well the EQ-5D-5L will function, and so a dementia-specific QoL
measure, DEMQOL, will also be utilised.
Sample size
We estimate that care transition occurs in 50% of people with demen-
tia in the last year of life.5,23 A total of 294 will be recruited. Allowing
for 25% attrition, we expect 110 to have a transition. Primary analysis
is based on logistic regression models. Using the rule of 10 events
(in this case, transitions) per variable, this allows estimation of
11 regression coefficients for a logistic regression model with ade-
quate precision.40 Prion dementias sample size estimated 50 partici-
pants over an 18-month recruitment period based on approximately
120 new cases per year.
Analysis
We will describe participant characteristics and quantitative out-
come measures using mean/median (SD, IQ range) and counts (per-
centage) as appropriate. We will investigate bias from missing data
and use multiple imputation for missing values of explanatory vari-
ables if considered appropriate. Logistic regression accounting for
whether patients are recruited from care homes or the community
will be used to estimate the associations between pre-specified
explanatory variables such as unmet needs and outcomes, ie, first
care transition during the study. To explore trends in IPOS-Dem,
comfort, symptom management, and care transitions over time, we
will use regression models that can incorporate repeated
measurements.
We will explore further unmet needs and care transitions using
individual interviews comprising dyads of a person with dementia
(when possible) and a carer (ie, family). We will interview separately
the main practitioner involved in providing care identified by the fam-
ily to understand their perspective. Interview data will undergo the-
matic analysis, triangulated with our quantitative data. A third DEEP
workshop will consider implications of findings for people with
dementia, key messages for policymakers and commissioners, and
how they should inform care.
3.5.4 | WS 4: Knowledge synthesis for
intervention development
This critical step of the EMBED-Care programme will synthesise
knowledge into a product (the intervention) to enable translation of
research evidence into practice as part of the KTA Framework.41 This
innovative approach moves beyond traditional evidence-based guide-
lines, by incorporating information about existing practice and policy
and the resources needed in different contexts. Our complex inter-
vention will require synthesis of diverse types of knowledge, in differ-
ing formats, with varying degrees of value, to be robust, reliable, and
practical for implementation in real world settings.42 We will syn-
thesise data from WSs 1 to 3, our work on IPOS-Dem30 and the heu-
ristic decision aid.25 We will systematically evaluate evidence for
strategies to address unmet needs, incorporating them into a knowl-
edge synthesis matrix (for an example of this, see Table 2). This pivotal
step of the KTA links knowledge creation with action to support
effective uptake by potential end users.
The matrix will be based on framework analysis,43 a method for
synthesising applied qualitative data, adapted to include the results
of quantitative effectiveness studies and meta analyses. Existing
evidence-based approaches consider RCT and meta-analysis evidence
as the gold standard; however, these can fail to account for the impact
of context, policy, resources, and mechanisms underlying interven-
tions that enable or inhibit translation into practice.44 Using this
approach, multiple strategies can be assessed against unmet needs;
eg, there may be strong evidence that repositioning improves pres-
sure sores but not pain. The matrix provides a comprehensive synthe-
sis of best available evidence, providing recommendations for
intervention development. Focus groups with key professionals will
consider and provide feedback on the emerging results before trans-
lating the matrix into a practical, multi-component intervention. A
DEEP workshop will be held to ensure our findings are relevant to
people with dementia.
3.5.5 | WS 5: Co-design of intervention to support
better palliative dementia care
Our aim is to co-design with people with dementia, carers, and staff, an
innovative complex intervention to enable and empower assessment
and management of needs, develop person-centred care, and integrate
palliative dementia care into health and social care practice. The
EMBED-Care intervention will likely comprise as follows:
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1. A resource to holistically assess and identify concerns and symp-
toms, prioritise needs and goals by the person with dementia and
their carer or staff, and trigger alerts of changing or unmet needs
(IPOS-Dem).
2. A heuristic decision resource detailing evidence-based actions to
enable staff and/ or carers to put in place the right care, at the
right time, in the right place.
3. An intervention manual and training and support package for staff.
We will consider the use of telehealth as a key mode of delivery.
We will use the WS 4 knowledge synthesis to develop prototype deci-
sion aids. We will work with co-design45 groups involving practi-
tioners, current and former carers, and people with mild dementia.
This allows collaboration on intervention design and delivery between
researchers and end users to promote successful implementation and
translation into practice46 and links knowledge creation with action in
our KTA framework.36 Co-design groups will iteratively refine the
heuristic resource. A training and support package will be designed
and reviewed in a final workshop. The intervention will be field tested
in practice (home and care home settings) for 4 weeks, and after this,
we will hold a focus group to explore use barriers and facilitators, con-
tent and design, and modifications to implementation or delivery.
3.5.6 | WS 6 Feasibility study
We will conduct a feasibility study of intervention implementation
and recruitment and then pilot the intervention in a cluster RCT. Clus-
ters will be individual care homes or communities of practice. We will
refine the intervention, inform the design of future studies, and estab-
lish whether a future definitive trial is warranted. To ensure methodo-
logical rigour, we are supported by an MRC-registered clinical trials
unit (PRIMENT-CTU), who will be involved at all stages: planning,
approvals, randomisation, data collection, storage, and analysis. We
will need to be flexible with feasibility and pilot trial design to allow
for likely changes in health and social care systems during the pro-
gramme. Detailed methods will be informed by WSs 1 to 5. For exam-
ple, potential outcome measures will likely include care transitions,
comfort and service use, but selection will be informed by programme
theory (WS 1). Participant recruitment criteria, including carers, will be
guided by WSs 2 and 3 and PPI consultation. Both feasibility and pilot
studies will use mixed methods, informed by the MRC framework for
complex intervention development47 and MORECare48,49 guidance
for palliative and social care, which defines best practice to develop
and evaluate models of service delivery and complex interventions in
palliative and end-of-life care.
The feasibility study will run the intervention for 3 months,
supported by a champion in each care setting. We will test the feasi-
bility of data collection at baseline and 3 months. We will evaluate
acceptability of the intervention and conduct a process evaluation to
understand risks of harm, implementation requirements, and context-
specific adaptations.50 We will use data from a range of organisational
levels and informants. For example, clinical commissioning group ser-
vice data to examine unplanned care transitions to hospital and a util-
ity questionnaire for staff to explore practical use of the tools. Semi-
structured interviews/focus groups in each cluster, detailed case stud-
ies, observations of multidisciplinary meetings, and case note review
will inform adaptations. Final consultation with potential end users
will employ consensus methods to make recommendations on inter-
vention components and implementation requirements.51
The pilot cluster RC will run for 6 months in six clusters (three
intervention and three control). Outcome measures will be identified
from the feasibility study. Data will be collected on people with
dementia and their carers at baseline and monthly. Levels of missing
data will be assessed and evaluated. Recruitment and attrition rates
will be estimated using proportions with associated 95% CI. We will
estimate the difference (with 95% CI) in our main clinical outcomes
between trial arms, using appropriate regression models adjusted for
baseline values. This will inform sample size calculations for a full clus-
ter RCT. We will assess intervention fidelity and hold focus groups
and semi-structured interviews with people with dementia, carers,
and health and social care staff. We will test recruitment processes,
whether outcome data can be collected by researchers blind to alloca-
tion, implementation, and identify stop-go criteria for a full trial.
3.6 | Key outputs from EMBED-Care
We will ensure that EMBED-Care produces outputs that benefit peo-
ple with dementia, their family carers, practitioners, and wider society.
TABLE 2 Example of synthesis matrix for intervention development
Strategies for
Addressing
Unmet Needs
Unmet Needs
This Strategy
may Address
Source of Evidence
(WSs 1, 2, and 3 or
previous research)
Mechanism for
Addressing
Unmet Need
Consistency with
UK Policy and
Practice (from
WS 1)
Resources Needed for
Implementing in UK
Settings and Neglected
Populations and to
Meet Projected Needs
Identified in WS 2
Recommendation
Based on Current
Evidence?
Strategy 1 (new row for each unmet need)
Example 1:
repositioning
Pain WS 1 policy review
WS 3 cohort
Reduces discomfort,
pressure sores,
improves body
alignment
Carer and staff
interviews
Used in UK hospital and
care home settings;
implications on staff
time
Yes/no (identified
in WS 1)
Abbreviation: WS, work steam.
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Data sets and methodological developments will build research capac-
ity. The main outputs include the following:
• Conceptual framework for integrated palliative dementia care:
including key components and mechanisms of change, to underpin
all aspects of the programme. Theoretical work will expand notions
of “comfort,” “person-centredness,” and good death with dementia
to inform both theory and practice of care in society (All WSs).
• EMBED-Care intervention: which may be delivered via telehealth
technologies, with associated training materials and implementa-
tion guidance (WSs 5-6).
• Methodological development: innovation in data linkage (WS 2),
economic methods in palliative care (WS 3), synthesis of qualitative
and quantitative data and underlying theory (WS 4), and develop-
ment of intervention implementation theory and framework (WS 6).
• Data sets: new quantitative and qualitative data on palliative care
needs and outcomes in people with moderate dementia and their
carers, and the first data on young onset and prion dementias, will
be anonymised and made freely available. This will provide signifi-
cant scientific benefit to sociological, economic, gerontological, and
health researchers and a basis to develop and evaluate future inter-
ventions, instrument design, and services (WS 3).
• Future projections of need for palliative dementia care: to inform
service planning and commissioning (WS 2).
• Policy briefings/labs: to inform and brief policymakers and commis-
sioners together with practitioners and service users to enable
evidence-based policymaking.
• Knowledge exchange events: provide pathways to policy and aca-
demic impact (all WSs).
• Art installation: co-created in workshops with an artist to increase
outreach to groups who may not have engaged with the issue of
dying with dementia.
• YouGov poll: snapshot measure of societal attitudes towards dying
with dementia.
• Newsletters and blogs: co-developed with patient groups at key
milestones to contribute their perspective to policy briefings and
dissemination.
• Network for Excellence in Palliative Dementia Care: to boost the
impact of the research by uniting contributing practitioners, people
with dementia, carers, researchers, other stakeholders and existing
communities of practice, and international partners.
4 | DISCUSSION
The multidisciplinary team working on our programme will sequen-
tially build new epidemiological and social science knowledge on dying
with dementia and a new model of integrated palliative dementia care.
This will address unmet needs regardless of the severity of dementia
across a range of care settings. We will apply a person-centred
approach maximising comfort and QoL. Our multi-component inter-
vention will be carefully developed with attention to contextual fac-
tors such as adaptability to local models of service provision,
workforce capability, and economic factors. Our innovative combina-
tion of underpinning theory, implementation science, and co-design
methods will ensure adoption in practice and improved palliative care
for people with dementia and their carers.
This step change in care provision requires public support and
engagement, and therefore, changing societal attitudes towards dying
with dementia is key to our work, as demonstrated by our pathways
to impact that use a range of methods, from academic dissemination
to policy work and novel projects with young people who will be
affected by dementia in their future. Active and meaningful engage-
ment of people with dementia and their carers will shape all aspects
of our work. We will deliver new knowledge and interventions so that
people dying with dementia and their carers receive good quality palli-
ative care in the right place at the right time, delivered by a work force
with the skills necessary to achieve this.
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